CVC TECHNOLOGIES INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24 TWD | -0.21% |
|
-0.83% | -10.61% |
| Sales 2022 | 903M 27.73M | Sales 2023 | 1.13B 34.62M | Capitalization | 1.48B 45.33M |
|---|---|---|---|---|---|
| Net income 2022 | 56M 1.72M | Net income 2023 | 14M 430K | EV / Sales 2022 | 0.99 x |
| Net cash position 2022 | 181M 5.57M | Net cash position 2023 | 98.54M 3.03M | EV / Sales 2023 | 1.22 x |
| P/E ratio 2022 |
20
x | P/E ratio 2023 |
99.6
x | Employees | - |
| Yield 2022 |
3.77% | Yield 2023 |
0.37% | Free-Float | 69.13% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.21% | ||
| 1 week | -0.83% | ||
| Current month | +0.21% | ||
| 1 month | -0.83% | ||
| 3 months | -12.41% | ||
| 6 months | -23.93% | ||
| Current year | -10.61% |
1 week
23.30
24.40
1 month
23.0025.75
Current year
23.0029.90
1 year
23.0046.00
3 years
22.6046.00
5 years
22.6046.00
10 years
8.3950.00
| Managers | Title | Age | Since |
|---|---|---|---|
Kai Hsun Chang
CEO | Chief Executive Officer | - | - |
Chin Chia Chang
DFI | Director of Finance/CFO | - | - |
Ching Mei Lin
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
Chang Hsi Yang
BRD | Director/Board Member | 74 | - |
Te Hsin Yan
CHM | Chairman | - | 20-06-17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 24 | -0.21% | 106,806 |
| 24-04-23 | 24.05 | +1.69% | 135,186 |
| 24-04-22 | 23.65 | 0.00% | 161,425 |
| 24-04-19 | 23.65 | -2.47% | 236,437 |
| 24-04-18 | 24.25 | +0.21% | 157,589 |
End-of-day quote Taipei Exchange, April 23, 2024
More quotes
CVC Technologies Inc. is principally engaged in the manufacture and sales of pharmaceutical packaging equipment. The Company's products include tablet and capsule counting production lines, liquid filling lines, powder production lines and optical detectors. Its tablet and capsule counting production lines are mainly applied to the bottled packaging production of tablets and capsules. Its liquid filling lines are mainly applied to the bottled packaging production of oral solutions. Its powder production lines are mainly applied to the bottled packaging production of drug powder. Its optical detectors are mainly applied to the inspection of various packaged bottled pharmaceutical agents for injection applications. The Company mainly distributes its products in America, India and Mainland China.
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -10.61% | 40.41M | |
| -1.55% | 14.87B | |
| +28.88% | 5.3B | |
| -11.99% | 4.79B | |
| -10.55% | 4.93B | |
| +8.94% | 4.17B | |
| -18.88% | 4.03B | |
| +20.86% | 4.1B | |
| +28.18% | 3.54B | |
| +1.99% | 3.35B |
- Stock Market
- Equities
- 4744 Stock
